• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Use of psychiatric medications may be associated with a higher risk of amyotrophic lateral sclerosis

bySimon PanandAlex Chan
June 12, 2025
in Chronic Disease, Neurology, Psychiatry
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Prediagnostic use of anxiolytics, hypnotics, sedatives and antidepressants were associated with a higher risk of amyotrophic lateral sclerosis (ALS). 

Evidence Rating Level: 2 (Good)

While ALS has been historically recognized as a disease affecting the motor neurons, psychiatric symptoms have also been shown to be a manifestation of ALS. Studies investigating the relationship between psychiatric medication use and the risk of developing ALS are limited. This case-control study therefore sought to investigate the association between the use of anxiolytics, hypnotics, sedatives and antidepressants and the risk of developing ALS as well as the progression of ALS. 1057 case participants and 5281 controls (mean[SD] age, 67.5[11.5] years; 53.% male) were included from the Swedish MND Quality Registry between January 2015 and July 2023. Following multivariable adjustment, having at least 2 prescriptions of psychiatric medications was associated with an increased risk of developing ALS when the medications were prescribed 0-1, 1-5 and greater than 5 years before development of ALS (prescribed hypnotics and sedatives 0-1 years befor index date: odds ratio [OR], 6.10; 95% CI, 3.77-9.88; prescribed anxiolytics 1-5 years before index date: OR, 1.60; 95% CI, 1.15-2.23; prescribed antidepressants >5 years before index date: OR, 1.21; 95% CI, 1.02-1.44). Following multivariable adjustment, prescribed use of anxiolytics and antidepressants were associated with an increased risk of mortality (hazard ratio [HR], 1.52; 95% CI, 1.12-2.05 and HR, 1.72; 95% CI, 1.30-2.29, respectively). Overall, this study found that prediagnostic prescribed use of anxiolytics, hypnotics, sedatives and antidepressants were associated with higher risk of developing ALS. 

Click to read the study in JAMA Network Open

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

RELATED REPORTS

MLC901 may be effective in treatment of post-concussion symptoms in phase III study

Risk of dementia increased with gabapentin prescription in back pain patients

New-generation antiseizure medications are better tolerated for patients with epilepsy

Tags: antipsychotic medicationsneurologyperipheral neurologypharmacologypsychiatry
Previous Post

Nivolumab plus ipilimumab improves survival over lenvatinib or sorafenib in liver cancer

Next Post

#VisualAbstract: Encorafenib, Cetuximab, and mFOLFOX6 Improves Survival in BRAF-Mutated Colorectal Cancer

RelatedReports

Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial
Chronic Disease

MLC901 may be effective in treatment of post-concussion symptoms in phase III study

July 17, 2025
Quick Take: Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine
Chronic Disease

Risk of dementia increased with gabapentin prescription in back pain patients

July 17, 2025
Chronic Disease

New-generation antiseizure medications are better tolerated for patients with epilepsy

July 16, 2025
Intensive rehabilitation not superior to traditional therapy for arm function after stroke
Emergency

Thrombolysis-to-puncture time greater than 70 minutes decreases odds of successful thrombectomy

July 15, 2025
Next Post
#VisualAbstract: Encorafenib, Cetuximab, and mFOLFOX6 Improves Survival in BRAF-Mutated Colorectal Cancer

#VisualAbstract: Encorafenib, Cetuximab, and mFOLFOX6 Improves Survival in BRAF-Mutated Colorectal Cancer

Colchicine may lower the risk of cardiovascular events in patients with coronary disease

Transcatheter closure of patent ductus arteriosus demonstrates similar outcomes compared to surgical repair

Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial

2 Minute Medicine Rewind June 16, 2025

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Neoadjuvant and Adjuvant Pembroli-zumab Increased Survival in Locally Advanced Head and Neck Cancer
  • MLC901 may be effective in treatment of post-concussion symptoms in phase III study
  • Risk of dementia increased with gabapentin prescription in back pain patients
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.